Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Mesenchymal Stromal Cells as Treatment or Prophylaxis for Acute or Chronic Graft‐versus‐host Disease in Haematopoietic Stem Cell Transplant (HSCT) Recipients With a Haematological Condition." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432099/all/. Accessed 16 May 2024.
Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432099/all/. Accessed May 16, 2024.
Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432099/all/
Mesenchymal Stromal Cells as Treatment or Prophylaxis for Acute or Chronic Graft‐versus‐host Disease in Haematopoietic Stem Cell Transplant (HSCT) Recipients With a Haematological Condition [Internet]. In: Cochrane Abstracts. [cited 2024 May 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432099/all/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition
ID - 432099
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432099/all/
DB - Evidence Central
DP - Unbound Medicine
ER -